Pfizer Inc November 5, 2021 10:30 am Pfizer: Our New COVID-19 Pill Cuts Severe Illness by 89% Pfizer says the company stopped clinical trials for its new coronavirus antiviral treatment early because the data was overwhelmingly successful. Local 1:32 Symptoms, spread and more: What to know about new COVID ‘FLiRT' variants 2:15 CDC could remove 5-day isolation recommendation for COVID: Report 2:55 Flu, COVID, RSV rising at Chicago hospitals, doctor says 1:50 IDPH says COVID-19 hospitalizations are on the rise in parts of Illinois 0:25 COVID symptoms 2023: Chicago-area doctor reveals what she's seeing most